A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Clinical trial NCT03416179 · COMPLETED

Trial details

NCT number: NCT03416179
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2018-04-20
Primary completion: 2020-06-05
Enrollment: 730

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.